TABLE 1.
Baseline and on admission characteristics
| Baseline characteristics | Admission features | |||||||
|---|---|---|---|---|---|---|---|---|
| Patient. (Admission date) | Gender /Age (years) | Transplantation date (n previous transplant) | Cardiovascular risk factors | Day of symptoms when admission | X-ray | Oxygen Requirement | Renal function CKD-EPI mL/min (AKI) | |
| Group 1 | P 1 (03.13.2020) | F (74) | 2005 (1) | HBP, DL, OB, DM | 2 (F*) | BPS | None | 80.0 (No) |
| P 2 (03.16.2020) | M (50) | 2003 (1) | HBP, DL | 4 (F*, M*) | No infiltrates | None | 36.0 (No) | |
| P 3 (03.17.2020) | M (71) | 2012 (2) | HBP, DL | 4 (F*, C, M*, D) | No infiltrates | None | 15.0 (No) | |
| P 5 (03.17.2020) | F (66) | 2008 (1) | DL, OB | 7 (F*, C, M*, D, Dy) | LPS | NG | 21.0 (Yes) | |
| P 6 (03.17.2020) | F (66) | 2011 (1) | HBP, OB | 0 (CF) | No infiltrates | None | 80.0 (No) | |
| P 7 (03.19.2020) | F (63) | 2018 (1) | HBP, DL, OB | 4 (M*, Dy) | No infiltrates | None | 44.0 (No) | |
| Group 2 | P 4 (03.17.2020) | M (66) | 2014 (1) | HBP, DL | 8 (F*, C, M*, Dy) | No infiltrates | None | 27.7 (No) |
| P 8 (03.19.2020) | M (75) | 2006 (1) | HBP, DL | 0 (CF) | No infiltrates | None | 46.0 (No) | |
| P 9 (03.25.2020) | M (71) | 2009 (1) | HBP, DL, OB, DM | 12 (F*, C, M*, Dy) | LPS | NG | 33.0 (Yes) | |
| P 10 (03.26.2020) | M (68) | 2006 (1) | HBP, DL, DM | 1 (F*, C, M*, D, Dy) | BPS | NG | 93.0 (No) | |
| P 11 (03.27.2020) | M (45) | 2005 (1) | HBP, DL | 4 (F*, M*, D, Dy) | BPS | VM | 11.0 (Yes) | |
| P 12 (03.27.2020) | M (63) | 2020 (1) | HBP, DL, DM | 7 (F*, C, M*, D, Dy) | BPS | VM | 11.9 (Yes) | |
| P 13 (03.27.2020) | M (79) | 2006 (1) | HBP, DM | 30 (F*, C, M*, D, Dy) | No infiltrates | None | 16.0 (Yes) | |
| P 14 (03.30.2020) | M (28) | 2012 (1) | HBP, DL | 10 (F*, C, M*, D) | LPS | None | 30.0 (Yes) | |
| P 15 (03.31.2020) | F (48) | 2001 (1) | HBP, DL, OB | 7 (F*, C, M*) | BPS | None | 91.6 (No) | |
| P 16 (04.01.2020) | F (38) | 2015 (4) | HBP, DL | 7 (F*, M*, Dy) | LPS | None | 17.0 (Yes) | |
| P 17 (04.02.2020) | M (69) | 2018 (1) | HBP, DL, OB | 7 (F*, C, T, M*) | LPS | None | 48.0 (Yes) | |
| P 18 (04.02.2020) | M (63) | 2011 (1) | HBP, DL, OB, DM | 5 (F*, C, D, Dy) | LPS | None | 30.0 (Yes) | |
| P 19 (04.04.2020) | F (69) | 2019 (1) | HBP, DL, OB, DM | 0 (CF) | LPS | None | 13.0 (Yes) | |
| P 20 (04.06.2020) | M (63) | 2019 (1) | HBP, OB, DM | 5 (F*, C, D) | BPS | None | 9.40 (No) | |
| P 21 (04.06.2020) | F (56) | 2006 (1) | HBP, DL, OB | 7 (C, M*, D) | LPS | None | 43.5 (No) | |
| P 22 (04.06.2020) | M (63) | 2018(2) | HBP, DL, OB, DM | 3 (M*, Dy) | BPS | VM | 8.0 (Yes) | |
| P 23 (04.06.2020) | M (43) | 2013 (1) | HBP, DL, OB, DM | 7 (F*, C, D) | BPS | None | 21.3 (Yes) | |
| P 24 (04.07.2020) | M (73) | 2019 (1) | HBP, DL, OB, DM | 10 (F*, M*) | No infiltrates | None | 25.0 (No) | |
| P 25 (04.09.2020) | M (65) | 2010 (1) | HBP | 1 (F*, M*, D) | No infiltrates | None | 19.0 (Yes) | |
| P 26 (04.10.2020) | M (80) | 2007 (1) | HBP, DL, OB | 3 (F*, C, Dy), | BPS | NG | 25.0 (No) | |
| P 27 (04.14.2020) | F (80) | 2018(1) | HBP, DL. OB | 6 (M*) | No infiltrates | None | 31.7 (No) | |
| P 28 (04.14.2020) | F (64) | 2019 (1) | HPB, DL | 2 (C, D, Dy) | No infiltrates | None | 71.6 (No) | |
| P 29 (04.24.2020) | F (78) | 2000 (1) | HBP, DL, | 3 (M*, C, D, Dy) | LPS | None | 20.7 (Yes) | |
Abbreviations: AKI, acute kidney injury; BPS, bilateral patchy shadowing; C, cough; CF, casual findings of pulmonary infiltrates in computed tomography; CKD-EPI, Chronic Kidney Disease Epidemiology Collaboration; D, diarrhea; DL, dyslipidemia; DM, diabetes mellitus; Dy, dyspnea; F*= fever; F, female; HBP, hyper blood pressure; LPS, local patchy shadowing; M*= myalgias; M, male; NG, nasal glasses (2-3 lpm); OB, obesity; VM, venturi mask (8-10 lpm).